Thursday, September 10, 2026
The Cancer News
AN AUTHORITATIVE RESOURCE FOR EVERYTHING ABOUT CANCER
Preetesh Jain, MD, DM, PhD
Mays Cancer Center, UT Health San Antonio
hematology-oncology clinical investigator
Published Articles (1)
Mantle Cell Lymphoma in 2026: Auto-Transplant's Role Is fading, BTKi Combinations Are Frontline, and Brexu-cel Has Five-Year Data in RR-MCL
June 9, 2026
Mantle cell lymphoma is biologically diverse, clinically unpredictable, and historically difficult to treat with sustained efficacy.